&w=3840&q=100)
Godfrey Phillips Q4 results: Profit up 30% at ₹279.61 cr, expenses down 43%
Godfrey Phillips India Limited has reported a profit after tax (PAT) of ₹279.61 crore in the fourth quarter of financial year 2024–25, up 29.98 per cent from ₹215.12 crore in the corresponding quarter last year.
Revenue from contracts with customers surged 74 per cent year-on-year to ₹1,880.22 crore in Q4FY25, compared to ₹1,079.94 crore in Q4FY24.
However, revenue from operations declined 41 per cent to ₹1,106.64 crore in Q4FY25, down from ₹1,887.79 crore in the same quarter of FY24.
Similarly, total income fell 40 per cent year-on-year to ₹1,171.48 crore in Q4FY25, compared to ₹1,965.44 crore in Q4FY24.
On the expenses front, the company reported a 43 per cent decrease in total expenses at ₹947.63 crore in Q4FY25, down from ₹1,663.92 crore in the corresponding quarter of FY24.
For the full financial year, net profit increased by 21.31 per cent to ₹1,072.31 crore, up from ₹883.97 crore in FY24.
In FY25, revenue from operations grew 38 per cent to ₹6,767.49 crore, compared to ₹4,903.33 crore in FY24.
Godfrey Phillips has also announced a final dividend of 3,000 per cent, translating to ₹60 per equity share of face value ₹2 each, for the financial year ended 31 March 2025. The dividend is subject to shareholder approval at the company's upcoming Annual General Meeting (AGM).
In Q4FY25, revenue from the Cigarettes, Tobacco and related products segment rose 73.8 per cent to ₹1,865.89 crore, compared to ₹1,073.56 crore in Q4FY24.
For the full year FY25, revenue from this segment grew 38.6 per cent to ₹6,689.56 crore, up from ₹4,831.21 crore in FY24.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
2 hours ago
- Business Standard
Alembic Pharmaceuticals fixes record date for dividend
Record date is 29 July 2025Alembic Pharmaceuticals has fixed 29 July 2025 as record date for determining the entitlement of members of the Company to receive dividend for the financial year ended 31 March 2025. The payment of dividend will be made on or from Thursday, 7 August 2025, upon the same being approved at the Annual General Meeting scheduled to be held on 5 August 2025. Powered by Capital Market - Live News
Mint
3 hours ago
- Mint
Alembic Pharma shares rise after announcement of record date for dividend payment. Details here
Alembic Pharma share price rose nearly 2% following the declaration of the record date for dividend distribution. Alembic Pharmaceuticals has set Tuesday, 29th July, 2025, as the record date to identify the members eligible to receive dividends for the financial year concluding on 31st March, 2025. The dividend will be paid on or after Thursday, 7th August, 2025, following its approval at the Annual General Meeting planned for 5th August, 2025, as stated by the company in its filing to the exchange.
Mint
3 hours ago
- Mint
Tata Elxsi share price in focus as will trade ex-dividend today for dividend payout of ₹75 per share
Dividend Stock: Tata Elxsi share price will remain in focus on Wednesday as the stock will trade ex-dividend today, June 11. Tata Elxsi had set June 11, 2025, as the record date for identifying the list of eligible shareholders to receive the dividend. Record date for June 11 implies that the investors who wish to benefit from the dividend payout announced by the company should have bought shares of Tata Elxsi at least one day before the record date, as per T+1 settlement procedure, for their names to appear in the list of eligible shareholders to receive the dividend payout. As per a release by Tata Elxsi, dividends on shares held in physical form will be paid to members whose names are included in the Register of Members as of Wednesday, June 11, 2025, at the end of work hours. Dividends on shares held in demat form will be paid to members whose names are included in the list of beneficial owners provided by the Depositories as of Wednesday, June 11, 2025, at the end of business hours. At its meeting on April 17, 2025, the company's board of directors proposed that members approve a dividend of ₹ 75 each equity share with a face value of ₹ 10 apiece at the 36th annual general meeting. The announcement amounted to a 750% dividend considering the face value of shares. The company had announced that on Wednesday, June 25, 2025, the company's 36th Annual General Meeting (AGM) will take place by video conference or other audio-visual means. If authorised, the dividend will be paid by June 30, 2025, at the latest, after the following tax deductions are made at the source. Tata Elxsi's share price on Tuesday had closed 1.10% higher on the BSE at ₹ 6703.50. "Tata Elxsi has witnessed a strong upside in recent times which is in line with the performance seen in many of the IT names, said Gaurav Bissa VP - InCred Equities. The RSI at the current levels has entered in an overbought zone which makes buying lucrative on dips towards ₹ 6350 levels where its 200dema is likely lend a strong support and price will also retest swing breakout making risk reward lucrative for a short term trade, added Bissa
